People who are treated with Pradaxa® (dabigatran etexilate) and who suffer internal bleeding, heart attack and/or other serious complications, may be eligible to seek compensation by filing a Pradaxa® lawsuit.
(PRWEB) September 28, 2012
According to Flood Law Group, LLP, people who are treated with Pradaxa® (dabigatran etexilate) and who suffer internal bleeding, heart attack and/or other serious complications, may be eligible to seek compensation by filing a Pradaxa® lawsuit. Families of individuals who died while taking the medication may also be eligible for compensation.
Pradaxa®, which is prescribed to reduce the risk of stroke in patients with non-valvular atrial fibrillation (AF), has been prescribed to thousands of patients.
When the medication first hit the market it 2010, it was celebrated by doctors and patients. It seemed to be a safer, easier alternative to warfarin, the oldest stroke prevention medication on the market.
Warfarin, which is marketed under the brand name Coumadin, requires patients to stick to a limited diet and get weekly checkups from their doctors. Pradaxa®, on the other hand, requires far less doctor exams and has no food limitations. But, since the drug hit the market, thousands of patients have reported serious adverse effects, including irreversible internal bleeding events.
According to USA Today, the U.S. Food and Drug Administration (FDA) received 3,781 reports of adverse effects and 542 reports of death in patients taking Pradaxa® last year alone.
The link between anticoagulant medications and an increased risk for internal bleeding is not a new discovery. But, unlike warfarin, Pradaxa® internal bleeding events cannot be reversed. This, according to Flood Law Group, makes Pradaxa® a very dangerous drug.
In response to the high number of reports of adverse events, FDA issued a safety communication on Dec. 7, 2011, saying that it is evaluating post-marketing reports of severe bleeding events in people taking Pradaxa®.
“FDA is working to determine whether the reports of bleeding in patients taking Pradaxa® are occurring more commonly than would be expected, based on observations in the large clinical trial that supported the approval of Pradaxa®,” the FDA said in the safety communication.
Patients taking Pradaxa® should talk to their doctors about the risk of internal bleeding. They should be aware of the following signs and symptoms and visit their doctors immediately if they occur:
- Frequent nosebleeds
- Unexplained bleeding from the gums
- Coughing up blood
- Throw up that looks like coffee grounds
- Pink or brown colored urine
- Dark (tar-like) stools
In addition to life-threatening bleeding events, Pradaxa® has also been linked to an increase in the risk of heart attack and severe symptoms of heart disease.
About Flood Law Group, LLP
Flood Law Group, LLP helps patients and families that are affected by defective drugs seek compensation for their injuries. The attorneys at the firm are providing free case reviews for individuals and families affected by Pradaxa®.
For more information about the possible side effects of Pradaxa® or to schedule a free review of your case, please call 1-888-365-8938.